Both Th1 and Th2 CD4 + T-Cell Lineage Infiltrations Decrease in Post-hematopoietic Stem Cell Transplantation Colon Adenoma-Reference-Cited by-同舟云学术

Both Th1 and Th2 CD4 + T-Cell Lineage Infiltrations Decrease in Post-hematopoietic Stem Cell Transplantation Colon Adenoma

Published:2024-08-19 Issue: Volume: Page:
ISSN:1941-6628
Container-title:Journal of Gastrointestinal Cancer
language:en
Short-container-title:J Gastrointest Canc

Author:

Matsubara Yasuo^ORCID,Ota Yasunori,Denda Tamami,Tanaka Yukihisa,Isobe Masamichi^ORCID,Kato Seiko,Konuma Takaaki^ORCID,Takahashi Satoshi^ORCID,Hirata Yoshihiro^ORCID,Ikematsu Hiroaki,Baba Keisuke^ORCID,Boku Narikazu^ORCID

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s12029-024-01097-5.pdf

Reference33 articles.

1. Little MT, Storb R. History of haematopoietic stem-cell transplantation. Nat Rev Cancer. 2002;2:231–8. https://doi.org/10.1038/nrc748.

2. Copelan EA. Hematopoietic stem-cell transplantation. N Engl J Med. 2006;354:1813–26. https://doi.org/10.1056/NEJMra052638.

3. Heydari K, Shamshirian A, Lotfi-Foroushani P, Aref A, Hedayatizadeh-Omran A, Ahmadi M, Janbabei G, Keyhanian S, Zaboli E, Ghasemzadeh SM, Alizadeh-Navaei R. The risk of malignancies in patients receiving hematopoietic stem cell transplantation: a systematic review and meta-analysis. Clin Transl Oncol. 2020;22:1825–37. https://doi.org/10.1007/s12094-020-02322-w.

4. Park SS, Park SH, Han S. Risk of secondary nonhematologic malignancies after allogeneic stem cell transplantation: a nationwide case-control cohort study. Int J Cancer. 2022;151:1024–32. https://doi.org/10.1002/ijc.34115.

5. Atsuta Y, Suzuki R, Yamashita T, Fukuda T, Miyamura K, Taniguchi S, Iida H, Uchida T, Ikegame K, Takahashi S, Kato K, Kawa K, Nagamura-Inoue T, Morishima Y, Sakamaki H, Kodera Y, Japan Society for Hematopoietic Cell Transplantation. Continuing increased risk of oral/esophageal cancer after allogeneic hematopoietic stem cell transplantation in adults in association with chronic graft-versus-host disease. Ann Oncol. 2014;25:435–41. https://doi.org/10.1093/annonc/mdt558